Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 2
2016 2
2018 2
2019 1
2020 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
TIF1-gamma IgG2 isotype is not associated with malignancy in juvenile dermatomyositis patients.
Nguyen HD, Jouen F, Déchelotte B, Cordel N, Gitiaux C, Bodemer C, Quartier P, Belot A, O'Brien K, Cancemi D, Melki I, Fabien N, Tansley S, Boyer O, Wedderburn LR, Bader-Meunier B; UK JDM Cohort and Biomarker Study. Nguyen HD, et al. Rheumatology (Oxford). 2024 Oct 1;63(10):e281-e284. doi: 10.1093/rheumatology/keae182. Rheumatology (Oxford). 2024. PMID: 38498839 Free PMC article. No abstract available.
Strategies for the prevention and management of methotrexate-related nausea and vomiting in juvenile idiopathic arthritis: results of a UK Paediatric Rheumatology prescriber survey.
Amin TS, Shenton S, Mulligan K, Wedderburn LR, Wood M, VanRooyen V, Leone V. Amin TS, et al. Among authors: vanrooyen v. Rheumatology (Oxford). 2015 Nov;54(11):2108-9. doi: 10.1093/rheumatology/kev259. Epub 2015 Jul 23. Rheumatology (Oxford). 2015. PMID: 26209331 No abstract available.
Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features.
Yasin SA, Schutz PW, Deakin CT, Sag E, Varsani H, Simou S, Marshall LR, Tansley SL, McHugh NJ, Holton JL, Wedderburn LR, Jacques TS; UK Juvenile Dermatomyositis Research Group (UK and Ireland). Yasin SA, et al. Neuropathol Appl Neurobiol. 2019 Aug;45(5):495-512. doi: 10.1111/nan.12528. Epub 2019 Mar 11. Neuropathol Appl Neurobiol. 2019. PMID: 30378704 Free PMC article.
Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis.
Deakin CT, Yasin SA, Simou S, Arnold KA, Tansley SL, Betteridge ZE, McHugh NJ, Varsani H, Holton JL, Jacques TS, Pilkington CA, Nistala K, Wedderburn LR; UK Juvenile Dermatomyositis Research Group. Deakin CT, et al. Arthritis Rheumatol. 2016 Nov;68(11):2806-2816. doi: 10.1002/art.39753. Epub 2016 Oct 9. Arthritis Rheumatol. 2016. PMID: 27214289 Free PMC article.
Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease.
Varsani H, Charman SC, Li CK, Marie SK, Amato AA, Banwell B, Bove KE, Corse AM, Emslie-Smith AM, Jacques TS, Lundberg IE, Minetti C, Nennesmo I, Rushing EJ, Sallum AM, Sewry C, Pilkington CA, Holton JL, Wedderburn LR; UK Juvenile Dermatomyositis Research Group. Varsani H, et al. Ann Rheum Dis. 2015 Jan;74(1):204-10. doi: 10.1136/annrheumdis-2013-203396. Epub 2013 Sep 24. Ann Rheum Dis. 2015. PMID: 24064003 Free PMC article.
Comparison of the Utility and Validity of Three Scoring Tools to Measure Skin Involvement in Patients With Juvenile Dermatomyositis.
Campanilho-Marques R, Almeida B, Deakin C, Arnold K, Gallot N, de Iorio M, Nistala K, Pilkington CA, Wedderburn LR; Juvenile Dermatomyositis Research Group. Campanilho-Marques R, et al. Arthritis Care Res (Hoboken). 2016 Oct;68(10):1514-21. doi: 10.1002/acr.22867. Epub 2016 Sep 16. Arthritis Care Res (Hoboken). 2016. PMID: 26881696 Free PMC article.